Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Naohiro Tomita, Katsuyuki Kunieda, Atsuyuki Maeda, Chikuma Hamada, Takeharu Yamanaka, Toshihiko Sato, Kazuhiro Yoshida, Narikazu Boku, Riichiro Nezu, Shigeki Yamaguchi, Hideyuki Mishima, Sotaro Sadahiro, Kei Muro, Megumi Ishiguro, Junichi Sakamoto, Shigetoyo Saji, Yoshihiko Maehara

ABSTRACT

BACKGROUND: Up to 6-months oxaliplatin-containing regimen is now widely accepted as a standard adjuvant chemotherapy for stage III colorectal cancer (CRC). However, oral fluoropyrimidine monotherapy is used for some part of patients, especially in Asian countries including Japan, and its optimal duration is yet to be fully investigated. METHODS: A total of 1306 patients with curatively-resected stage III CRC were randomly assigned to receive capecitabine (2500 mg/m2/day) for 14 out of 21 days for 6 (n = 654) or 12 (n = 650) months. The primary endpoint was disease-free survival (DFS), and the secondary endpoints were relapse-free survival (RFS), overall survival (OS), and adverse events. RESULTS: The 3- and 5-year DFS were 70.0% and 65.3% in the 6M group and 75.3% and 68.7% in the 12M group, respectively (p = 0.0549, HR = 0.858, 90% CI: 0.732-1.004). The 5-year RFS was 69.3% and 74.1% in the 6M and 12M groups, respectively (p = 0.0143, HR = 0.796, 90% CI: 0.670-0.945). The 5-year OS was 83.2% and 87.6%, respectively (p = 0.0124, HR = 0.727, 90% CI: 0.575-0.919). The incidence of overall grade 3-4 adverse events was almost comparable in both groups. CONCLUSIONS: Although 12-month adjuvant capecitabine did not demonstrate superior DFS to that of 6-month, the observed better RFS and OS in the 12-month treatment period could be of value in selected cases. More... »

PAGES

1-8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41416-019-0410-0

DOI

http://dx.doi.org/10.1038/s41416-019-0410-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112511546

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30833647


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hyogo College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.272264.7", 
          "name": [
            "Department of Surgery, Division of Lower Gastrointestinal Surgery, Hyogo College of Medicine, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomita", 
        "givenName": "Naohiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu Prefectural General Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.415536.0", 
          "name": [
            "Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kunieda", 
        "givenName": "Katsuyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ogaki Municipal Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416762.0", 
          "name": [
            "Department of Surgery, Ogaki Municipal Hospital, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maeda", 
        "givenName": "Atsuyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo University of Science", 
          "id": "https://www.grid.ac/institutes/grid.143643.7", 
          "name": [
            "Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamada", 
        "givenName": "Chikuma", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yokohama City University", 
          "id": "https://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamanaka", 
        "givenName": "Takeharu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yamagata Prefectural Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417323.0", 
          "name": [
            "Yamagata Prefectural Central Hospital, Yamagata, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Toshihiko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gifu University", 
          "id": "https://www.grid.ac/institutes/grid.256342.4", 
          "name": [
            "Department of Surgical Oncology, Gifu University, Graduate School of Medicine, Gifu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "Kazuhiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "National Cancer Center Hospital, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boku", 
        "givenName": "Narikazu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nishinomiya Municipal Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416305.5", 
          "name": [
            "Nishinomiya Municipal Central Hospital, Hyogo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nezu", 
        "givenName": "Riichiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saitama International Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412377.4", 
          "name": [
            "Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamaguchi", 
        "givenName": "Shigeki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aichi Medical University", 
          "id": "https://www.grid.ac/institutes/grid.411234.1", 
          "name": [
            "Cancer Center, Aichi Medical University, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mishima", 
        "givenName": "Hideyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokai University", 
          "id": "https://www.grid.ac/institutes/grid.265061.6", 
          "name": [
            "Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sadahiro", 
        "givenName": "Sotaro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aichi Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.410800.d", 
          "name": [
            "Aichi Cancer Center, Aichi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muro", 
        "givenName": "Kei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Medical and Dental University", 
          "id": "https://www.grid.ac/institutes/grid.265073.5", 
          "name": [
            "Department of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishiguro", 
        "givenName": "Megumi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Japanese Foundation for Multidisciplinary Treatment of Cancer", 
          "id": "https://www.grid.ac/institutes/grid.500401.0", 
          "name": [
            "Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakamoto", 
        "givenName": "Junichi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Japanese Foundation for Multidisciplinary Treatment of Cancer", 
          "id": "https://www.grid.ac/institutes/grid.500401.0", 
          "name": [
            "Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saji", 
        "givenName": "Shigetoyo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Japanese Foundation for Multidisciplinary Treatment of Cancer", 
          "id": "https://www.grid.ac/institutes/grid.500401.0", 
          "name": [
            "Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maehara", 
        "givenName": "Yoshihiko", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2011.05.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005613211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.65.3048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007595860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007749700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013306951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.7498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018390646"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.29210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018963471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.2974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019914632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2014.05.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020112311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14656566.2016.1145665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025639215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyq209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028046051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-016-1083-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032169203", 
          "https://doi.org/10.1007/s10147-016-1083-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-016-1083-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032169203", 
          "https://doi.org/10.1007/s10147-016-1083-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042555196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02214-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047764604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.00.5686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050806968"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-011-0315-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052442439", 
          "https://doi.org/10.1007/s10147-011-0315-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.10.065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.1.110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083031469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.30.4_suppl.388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083952556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.22.14_suppl.4142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084614152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1713709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101820878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1713709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101820878"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "BACKGROUND: Up to 6-months oxaliplatin-containing regimen is now widely accepted as a standard adjuvant chemotherapy for stage III colorectal cancer (CRC). However, oral fluoropyrimidine monotherapy is used for some part of patients, especially in Asian countries including Japan, and its optimal duration is yet to be fully investigated.\nMETHODS: A total of 1306 patients with curatively-resected stage III CRC were randomly assigned to receive capecitabine (2500\u2009mg/m2/day) for 14 out of 21 days for 6 (n\u2009=\u2009654) or 12 (n\u2009=\u2009650) months. The primary endpoint was disease-free survival (DFS), and the secondary endpoints were relapse-free survival (RFS), overall survival (OS), and adverse events.\nRESULTS: The 3- and 5-year DFS were 70.0% and 65.3% in the 6M group and 75.3% and 68.7% in the 12M group, respectively (p\u2009=\u20090.0549, HR\u2009=\u20090.858, 90% CI: 0.732-1.004). The 5-year RFS was 69.3% and 74.1% in the 6M and 12M groups, respectively (p\u2009=\u20090.0143, HR\u2009=\u20090.796, 90% CI: 0.670-0.945). The 5-year OS was 83.2% and 87.6%, respectively (p\u2009=\u20090.0124, HR\u2009=\u20090.727, 90% CI: 0.575-0.919). The incidence of overall grade 3-4 adverse events was almost comparable in both groups.\nCONCLUSIONS: Although 12-month adjuvant capecitabine did not demonstrate superior DFS to that of 6-month, the observed better RFS and OS in the 12-month treatment period could be of value in selected cases.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41416-019-0410-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "120"
      }
    ], 
    "name": "Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study", 
    "pagination": "1-8", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d51f8730ffaa427ea5c122fd1ffd2a225e250d8b60847a7a7b4e90d8bb76bf65"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30833647"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41416-019-0410-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112511546"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41416-019-0410-0", 
      "https://app.dimensions.ai/details/publication/pub.1112511546"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130823_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41416-019-0410-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0410-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0410-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0410-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0410-0'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      49 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41416-019-0410-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N43c21eb365134fdeb5bec1ee43559a7a
4 schema:citation sg:pub.10.1007/s10147-011-0315-2
5 sg:pub.10.1007/s10147-016-1083-9
6 https://doi.org/10.1002/ijc.29210
7 https://doi.org/10.1016/j.ejca.2014.05.025
8 https://doi.org/10.1016/s0140-6736(00)02214-5
9 https://doi.org/10.1053/j.seminoncol.2011.05.006
10 https://doi.org/10.1056/nejmoa032709
11 https://doi.org/10.1056/nejmoa043116
12 https://doi.org/10.1056/nejmoa1713709
13 https://doi.org/10.1093/annonc/mdv358
14 https://doi.org/10.1093/jjco/hyq209
15 https://doi.org/10.1200/jco.1997.15.1.110
16 https://doi.org/10.1200/jco.2003.10.065
17 https://doi.org/10.1200/jco.2004.00.5686
18 https://doi.org/10.1200/jco.2004.22.14_suppl.4142
19 https://doi.org/10.1200/jco.2005.04.7498
20 https://doi.org/10.1200/jco.2006.08.2974
21 https://doi.org/10.1200/jco.2012.30.4_suppl.388
22 https://doi.org/10.1200/jco.2015.65.3048
23 https://doi.org/10.1517/14656566.2016.1145665
24 schema:datePublished 2019-04
25 schema:datePublishedReg 2019-04-01
26 schema:description BACKGROUND: Up to 6-months oxaliplatin-containing regimen is now widely accepted as a standard adjuvant chemotherapy for stage III colorectal cancer (CRC). However, oral fluoropyrimidine monotherapy is used for some part of patients, especially in Asian countries including Japan, and its optimal duration is yet to be fully investigated. METHODS: A total of 1306 patients with curatively-resected stage III CRC were randomly assigned to receive capecitabine (2500 mg/m2/day) for 14 out of 21 days for 6 (n = 654) or 12 (n = 650) months. The primary endpoint was disease-free survival (DFS), and the secondary endpoints were relapse-free survival (RFS), overall survival (OS), and adverse events. RESULTS: The 3- and 5-year DFS were 70.0% and 65.3% in the 6M group and 75.3% and 68.7% in the 12M group, respectively (p = 0.0549, HR = 0.858, 90% CI: 0.732-1.004). The 5-year RFS was 69.3% and 74.1% in the 6M and 12M groups, respectively (p = 0.0143, HR = 0.796, 90% CI: 0.670-0.945). The 5-year OS was 83.2% and 87.6%, respectively (p = 0.0124, HR = 0.727, 90% CI: 0.575-0.919). The incidence of overall grade 3-4 adverse events was almost comparable in both groups. CONCLUSIONS: Although 12-month adjuvant capecitabine did not demonstrate superior DFS to that of 6-month, the observed better RFS and OS in the 12-month treatment period could be of value in selected cases.
27 schema:genre research_article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N7b92c6beee5940168793ed3fb2ed66db
31 Na8cd747e94ba4032808fc60251f4a3f3
32 sg:journal.1017082
33 schema:name Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study
34 schema:pagination 1-8
35 schema:productId N114adf6300a2461daea4b050ad6f51c2
36 N30e73d493353472f850b4b6b7239426a
37 N85c213272e12451c99de80873eb81a69
38 Na7f31443278e4b919709a99509d7cbd7
39 Nb85df15e6c504e74849be9b1cfeb8671
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112511546
41 https://doi.org/10.1038/s41416-019-0410-0
42 schema:sdDatePublished 2019-04-11T13:59
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher N6508b12bd54a45488f6bf9d3971b743c
45 schema:url https://www.nature.com/articles/s41416-019-0410-0
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N103be0c7eae2443d90289c7336e4a624 schema:affiliation https://www.grid.ac/institutes/grid.410800.d
50 schema:familyName Muro
51 schema:givenName Kei
52 rdf:type schema:Person
53 N11170863e276425fa95d4201dba1710f schema:affiliation https://www.grid.ac/institutes/grid.265073.5
54 schema:familyName Ishiguro
55 schema:givenName Megumi
56 rdf:type schema:Person
57 N114adf6300a2461daea4b050ad6f51c2 schema:name doi
58 schema:value 10.1038/s41416-019-0410-0
59 rdf:type schema:PropertyValue
60 N1982965e30fb437183b6ee00d352c691 schema:affiliation https://www.grid.ac/institutes/grid.411234.1
61 schema:familyName Mishima
62 schema:givenName Hideyuki
63 rdf:type schema:Person
64 N19b01256bc5e4ae5b74dcd293c04ca19 rdf:first Nc2f8d13154be464081d210a3ff320566
65 rdf:rest Nce3681d9936c44279d91b979f2e3600b
66 N1cafec6d27ae4776bc62648a6a9d485c schema:affiliation https://www.grid.ac/institutes/grid.415536.0
67 schema:familyName Kunieda
68 schema:givenName Katsuyuki
69 rdf:type schema:Person
70 N1cfe98ec28d243b0a999d8203d4f935c schema:affiliation https://www.grid.ac/institutes/grid.500401.0
71 schema:familyName Maehara
72 schema:givenName Yoshihiko
73 rdf:type schema:Person
74 N2819c60e67d74dca95508d175a6dc27c rdf:first N2fdffd10ec66493584af48eea1f5b384
75 rdf:rest Nfb6be86f9cab4da9a4ed7183554b97a3
76 N295b7f9a18a342f7b370e48056a03661 schema:affiliation https://www.grid.ac/institutes/grid.268441.d
77 schema:familyName Yamanaka
78 schema:givenName Takeharu
79 rdf:type schema:Person
80 N2af2e0430ba843499fe4c7832a13a596 rdf:first Nabf81c9b6d0447aca68057a21bda1fea
81 rdf:rest N64eb9dd7c0b044129650be42f4dbe760
82 N2fdffd10ec66493584af48eea1f5b384 schema:affiliation https://www.grid.ac/institutes/grid.143643.7
83 schema:familyName Hamada
84 schema:givenName Chikuma
85 rdf:type schema:Person
86 N30e73d493353472f850b4b6b7239426a schema:name nlm_unique_id
87 schema:value 0370635
88 rdf:type schema:PropertyValue
89 N39280d60673a41c1a897f27abb29d583 schema:affiliation https://www.grid.ac/institutes/grid.416762.0
90 schema:familyName Maeda
91 schema:givenName Atsuyuki
92 rdf:type schema:Person
93 N39c878082b074742aec6da0bbc0c4f7c rdf:first N103be0c7eae2443d90289c7336e4a624
94 rdf:rest Nde341105670645589644b1814093de6d
95 N4081f4be9c9d469ab3ed043d0e207773 schema:affiliation https://www.grid.ac/institutes/grid.500401.0
96 schema:familyName Sakamoto
97 schema:givenName Junichi
98 rdf:type schema:Person
99 N41775182a4e041da95e4f74cc6ed2968 rdf:first Nf7338259f7914c56b4be3da47610f50d
100 rdf:rest N7e77b8046a4e493b8edc4b64f09adb41
101 N43c21eb365134fdeb5bec1ee43559a7a rdf:first N9a0e147aeab940a2b3b7ce2dfa8a5a60
102 rdf:rest N60195e7278c24e3ab355352c500b6721
103 N53d682a88de642d5a9d282357808c39b rdf:first N4081f4be9c9d469ab3ed043d0e207773
104 rdf:rest N2af2e0430ba843499fe4c7832a13a596
105 N60195e7278c24e3ab355352c500b6721 rdf:first N1cafec6d27ae4776bc62648a6a9d485c
106 rdf:rest N622648fcd2ca4fd397152e2cf194e26a
107 N622648fcd2ca4fd397152e2cf194e26a rdf:first N39280d60673a41c1a897f27abb29d583
108 rdf:rest N2819c60e67d74dca95508d175a6dc27c
109 N64eb9dd7c0b044129650be42f4dbe760 rdf:first N1cfe98ec28d243b0a999d8203d4f935c
110 rdf:rest rdf:nil
111 N6508b12bd54a45488f6bf9d3971b743c schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N6e8155c873d4403ab1ce5d1944bbd457 rdf:first N8aae1d40fe3d4d669253bbc81bead832
114 rdf:rest N41775182a4e041da95e4f74cc6ed2968
115 N7b92c6beee5940168793ed3fb2ed66db schema:volumeNumber 120
116 rdf:type schema:PublicationVolume
117 N7e77b8046a4e493b8edc4b64f09adb41 rdf:first N1982965e30fb437183b6ee00d352c691
118 rdf:rest Ndf4ae9ef661e438eb3d93a4a73b4144b
119 N847b03ddcd1a4d14865abc17a5c825a2 rdf:first Na5401278ae6e4ac4b9714eda6af56663
120 rdf:rest N6e8155c873d4403ab1ce5d1944bbd457
121 N85c213272e12451c99de80873eb81a69 schema:name dimensions_id
122 schema:value pub.1112511546
123 rdf:type schema:PropertyValue
124 N8aae1d40fe3d4d669253bbc81bead832 schema:affiliation https://www.grid.ac/institutes/grid.416305.5
125 schema:familyName Nezu
126 schema:givenName Riichiro
127 rdf:type schema:Person
128 N8c42adbddaf243d9b7c063a7b5163d68 schema:affiliation https://www.grid.ac/institutes/grid.256342.4
129 schema:familyName Yoshida
130 schema:givenName Kazuhiro
131 rdf:type schema:Person
132 N9a0e147aeab940a2b3b7ce2dfa8a5a60 schema:affiliation https://www.grid.ac/institutes/grid.272264.7
133 schema:familyName Tomita
134 schema:givenName Naohiro
135 rdf:type schema:Person
136 Na5401278ae6e4ac4b9714eda6af56663 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
137 schema:familyName Boku
138 schema:givenName Narikazu
139 rdf:type schema:Person
140 Na7f31443278e4b919709a99509d7cbd7 schema:name readcube_id
141 schema:value d51f8730ffaa427ea5c122fd1ffd2a225e250d8b60847a7a7b4e90d8bb76bf65
142 rdf:type schema:PropertyValue
143 Na8cd747e94ba4032808fc60251f4a3f3 schema:issueNumber 7
144 rdf:type schema:PublicationIssue
145 Nabf81c9b6d0447aca68057a21bda1fea schema:affiliation https://www.grid.ac/institutes/grid.500401.0
146 schema:familyName Saji
147 schema:givenName Shigetoyo
148 rdf:type schema:Person
149 Nb85df15e6c504e74849be9b1cfeb8671 schema:name pubmed_id
150 schema:value 30833647
151 rdf:type schema:PropertyValue
152 Nc2f8d13154be464081d210a3ff320566 schema:affiliation https://www.grid.ac/institutes/grid.417323.0
153 schema:familyName Sato
154 schema:givenName Toshihiko
155 rdf:type schema:Person
156 Nce3681d9936c44279d91b979f2e3600b rdf:first N8c42adbddaf243d9b7c063a7b5163d68
157 rdf:rest N847b03ddcd1a4d14865abc17a5c825a2
158 Nde341105670645589644b1814093de6d rdf:first N11170863e276425fa95d4201dba1710f
159 rdf:rest N53d682a88de642d5a9d282357808c39b
160 Ndf4ae9ef661e438eb3d93a4a73b4144b rdf:first Nf9191a47b49743bcbd36f675a7625e22
161 rdf:rest N39c878082b074742aec6da0bbc0c4f7c
162 Nf7338259f7914c56b4be3da47610f50d schema:affiliation https://www.grid.ac/institutes/grid.412377.4
163 schema:familyName Yamaguchi
164 schema:givenName Shigeki
165 rdf:type schema:Person
166 Nf9191a47b49743bcbd36f675a7625e22 schema:affiliation https://www.grid.ac/institutes/grid.265061.6
167 schema:familyName Sadahiro
168 schema:givenName Sotaro
169 rdf:type schema:Person
170 Nfb6be86f9cab4da9a4ed7183554b97a3 rdf:first N295b7f9a18a342f7b370e48056a03661
171 rdf:rest N19b01256bc5e4ae5b74dcd293c04ca19
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
176 schema:name Oncology and Carcinogenesis
177 rdf:type schema:DefinedTerm
178 sg:journal.1017082 schema:issn 0007-0920
179 1532-1827
180 schema:name British Journal of Cancer
181 rdf:type schema:Periodical
182 sg:pub.10.1007/s10147-011-0315-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052442439
183 https://doi.org/10.1007/s10147-011-0315-2
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/s10147-016-1083-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032169203
186 https://doi.org/10.1007/s10147-016-1083-9
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/ijc.29210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018963471
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ejca.2014.05.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020112311
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/s0140-6736(00)02214-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047764604
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1053/j.seminoncol.2011.05.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005613211
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1056/nejmoa032709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042555196
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1056/nejmoa043116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013306951
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1056/nejmoa1713709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101820878
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1093/annonc/mdv358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007749700
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1093/jjco/hyq209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028046051
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1200/jco.1997.15.1.110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083031469
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1200/jco.2003.10.065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203898
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1200/jco.2004.00.5686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050806968
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1200/jco.2004.22.14_suppl.4142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084614152
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1200/jco.2005.04.7498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018390646
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1200/jco.2006.08.2974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019914632
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1200/jco.2012.30.4_suppl.388 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083952556
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1200/jco.2015.65.3048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007595860
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1517/14656566.2016.1145665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025639215
223 rdf:type schema:CreativeWork
224 https://www.grid.ac/institutes/grid.143643.7 schema:alternateName Tokyo University of Science
225 schema:name Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan
226 rdf:type schema:Organization
227 https://www.grid.ac/institutes/grid.256342.4 schema:alternateName Gifu University
228 schema:name Department of Surgical Oncology, Gifu University, Graduate School of Medicine, Gifu, Japan
229 rdf:type schema:Organization
230 https://www.grid.ac/institutes/grid.265061.6 schema:alternateName Tokai University
231 schema:name Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan
232 rdf:type schema:Organization
233 https://www.grid.ac/institutes/grid.265073.5 schema:alternateName Tokyo Medical and Dental University
234 schema:name Department of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.268441.d schema:alternateName Yokohama City University
237 schema:name Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.272242.3 schema:alternateName National Cancer Centre
240 schema:name National Cancer Center Hospital, Tokyo, Japan
241 rdf:type schema:Organization
242 https://www.grid.ac/institutes/grid.272264.7 schema:alternateName Hyogo College of Medicine
243 schema:name Department of Surgery, Division of Lower Gastrointestinal Surgery, Hyogo College of Medicine, Hyogo, Japan
244 rdf:type schema:Organization
245 https://www.grid.ac/institutes/grid.410800.d schema:alternateName Aichi Cancer Center
246 schema:name Aichi Cancer Center, Aichi, Japan
247 rdf:type schema:Organization
248 https://www.grid.ac/institutes/grid.411234.1 schema:alternateName Aichi Medical University
249 schema:name Cancer Center, Aichi Medical University, Aichi, Japan
250 rdf:type schema:Organization
251 https://www.grid.ac/institutes/grid.412377.4 schema:alternateName Saitama International Medical Center
252 schema:name Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Saitama, Japan
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.415536.0 schema:alternateName Gifu Prefectural General Medical Center
255 schema:name Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.416305.5 schema:alternateName Nishinomiya Municipal Central Hospital
258 schema:name Nishinomiya Municipal Central Hospital, Hyogo, Japan
259 rdf:type schema:Organization
260 https://www.grid.ac/institutes/grid.416762.0 schema:alternateName Ogaki Municipal Hospital
261 schema:name Department of Surgery, Ogaki Municipal Hospital, Gifu, Japan
262 rdf:type schema:Organization
263 https://www.grid.ac/institutes/grid.417323.0 schema:alternateName Yamagata Prefectural Central Hospital
264 schema:name Yamagata Prefectural Central Hospital, Yamagata, Japan
265 rdf:type schema:Organization
266 https://www.grid.ac/institutes/grid.500401.0 schema:alternateName Japanese Foundation for Multidisciplinary Treatment of Cancer
267 schema:name Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...